scorecardresearch
Add as a preferred source on Google
Friday, December 19, 2025
TopicCovaxin

Topic: Covaxin

Covishield production projected to reach 120 mn doses/month, Covaxin to 58 mn doses: Mandaviya

Health minister Mansukh Mandaviya while responding to a question on the current capacity to manufacture Covid vaccines said it is projected to go forward from August to December 2021.

Covaxin effective against Delta, other variants despite reduced antibody activity: ICMR study

Delta is believed to be one of the factors that catalysed India's second Covid wave. Further mutations in Delta have led to other variants, leading to concerns about vaccine efficacy.

CDSCO expert panel recommends nod to conduct trial of mixing Covaxin, Covishield doses

The study, conducted by Christian Medical College in Vellore, aims to assess whether a person can be given two different Covid vaccine shots to complete the inoculation course.

Brazil suspends decision to import 4 million doses of Bharat Biotech’s Covaxin

Brazil's decision came after Bharat Biotech terminated its pact with the country after its deal to supply 20 million Covaxin doses attracted investigation by Brazilian authorities.

How Brazil-Bharat Biotech deal for Covaxin crumbled in less than 30 days

The Jair Bolsonaro-led Brazil government cancelled Indian drugmaker Bharat Biotech’s emergency use authorisation request for its Covaxin vaccine on 24 July.

15 crore vaccine doses expected in August delays plan of 1 crore daily shots

Talks are still on with Moderna, Sputnik yet to be procured for the national Covid vaccination programme, which means Covishield and Covaxin will remain the mainstay.

Over 2.28 crore Covid vaccine doses still in stock with states, UTs, says health ministry

More than 45.73 crore vaccine doses have been supplied to states/UTs so far. Of this, total consumption, including wastage, stands at 43,80,46,844 doses, as per 8 am data Tuesday.

Brazil scraps Covaxin’s emergency use request after Bharat Biotech terminates vaccine pact

The termination came after the deal with the Brazilian Government for the supply of 20 million doses of the Covaxin landed in controversy and attracted investigation by authorities.

Brazil suspends Covaxin clinical trials after Bharat Biotech cancels vaccine pact

Bharat Biotech Friday announced cancellation of the MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its vaccine for the Brazilian market.

Assessing Covaxin data for emergency use listing, decision date yet to be confirmed: WHO

Suchitra Ella of Bharat Biotech said approval is not expected to be a long process as majority of Bharat Biotech's facilities have been audited and approved by WHO in the past.

On Camera

What the key political events of 2025 tell us about Narendra Modi and India’s future

From Operation Sindoor to India-US tensions to the EC controversies, a clear understanding has emerged about where the politics is headed now.

Antitrust watchdog Competition Commission to probe IndiGo flight disruptions

While the commission didn’t mention provisions under which IndiGo's market domination would be examined, Competition Act 2002 prohibits abuse of dominant position by any enterprise.

Israel has ‘realised who its real friend is’, eyes defence expansion in India amid arms curbs by others

It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.

India’s top airline just handed sarkar the keys. That’s IndiGo’s real ‘crime’

Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.